In preparation for NDA application and commercial production, Shanghai Xuantai produced a batch of B139A1901D for clinical research of new indications on a scale of 300,000 tablets.
In preparation for NDA application and commercial production, Shanghai Xuantai produced a batch of B139A1901D for clinical research on new indications on a scale of 300,000 tablets.
In preparation for NDA application and commercial production, Shanghai xuantai produced a batch of b139a1901d for clinical research of new indications on the scale of 300000 tablets.<br>